RU94016406A - Method of treatment of erysipelatous inflammation
- Google Patents
Method of treatment of erysipelatous inflammation
Info
Publication number
RU94016406A
RU94016406ARU94016406/14ARU94016406ARU94016406ARU 94016406 ARU94016406 ARU 94016406ARU 94016406/14 ARU94016406/14 ARU 94016406/14ARU 94016406 ARU94016406 ARU 94016406ARU 94016406 ARU94016406 ARU 94016406A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Уральский государственный медицинский институтfiledCriticalУральский государственный медицинский институт
Priority to RU94016406ApriorityCriticalpatent/RU2126659C1/en
Publication of RU94016406ApublicationCriticalpatent/RU94016406A/en
Application grantedgrantedCritical
Publication of RU2126659C1publicationCriticalpatent/RU2126659C1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
FIELD: medicine, in particular, cryotherapy. SUBSTANCE: inflammatory focus is subjected to the effect of liquid nitrogen for 20 to 25 s at a distance of 3 to 5 cm to the skin. EFFECT: reduced term of treatment of patients that are ill with erysipelatous inflammation.
Claims (1)
Сущность способа заключается в воздействии на воспалительный очаг жидким азотом в течение 20 - 25 с на расстоянии от кожи 3 - 5см. Способ позволяет сократить сроки лечения больных рожистым воспалением.The essence of the method consists in exposing the inflammatory focus to liquid nitrogen for 20 to 25 seconds at a distance from the skin of 3-5 cm. The method allows to reduce the treatment time for patients with erysipelas.
Method of treatment of acne or bread pseudofolliculitis, method of composition preparing, use of enzyme ornitine decarboxylase inhibitor for acne and bread folliculitis treatment
PROCEDURES FOR THE TREATMENT AND PROPHYLAXY OF PNEUMOCYTIS CARINII PNEUMONI AND OTHER DISEASES AND COMPOUNDS AND FORMULATIONS FOR USE IN THE ABOVE METHODS.
4,5-Diaryl-alpha-polyfluoroalkyl-1H-pyrrole-2-methanols and 1-(4,5-diaryl-1H-pyrrol-2-yl)-polyfluoroalkanones, processes for preparing them and pharmaceutical compositions.